RAFAEL HOLDINGS, INC. Convertible Notes Payable, Current
RAFAEL HOLDINGS, INC. (RFL) had Convertible Notes Payable, Current of $608.00 thousand as of 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2026-06-11
- 2026-04-30: Convertible Notes Payable, Current $608.00K.
- 2026-01-31: Convertible Notes Payable, Current $608.00K.
- 2025-07-31: Convertible Notes Payable, Current $614.00K.
- 2025-04-30: Convertible Notes Payable, Current $614.00K.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2026-04-30 | $608.00K 10-Q · filed 2026-06-11 |
| 2026-01-31 | $608.00K 10-Q · filed 2026-03-16 |
| 2025-07-31 | $614.00K 10-Q · filed 2026-06-11 |
| 2025-04-30 | $614.00K 10-Q · filed 2025-06-11 |
| 2025-01-31 | $614.00K 10-Q · filed 2025-03-14 |
| 2024-10-31 | $614.00K 10-Q · filed 2024-12-11 |
| 2024-07-31 | $614.00K 10-K · filed 2025-10-29 |
| 2024-04-30 | $614.00K 10-Q · filed 2024-06-14 |
| 2023-10-10 | $250.00M 10-Q · filed 2023-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |